Apolipoprotein A1 (APOA1) Antibody

Este producto es parte de APOA1 - Apolipoprotein A1
Product Graph
624€ (500 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Apolipoprotein A1 (APOA1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx411122
tested applications
ELISA, WB, IHC

Description

Apolipoprotein A-I (APOA1) Antibody is a Mouse Monoclonal antibody against APOLIPOPROTEIN A1.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Apolipoprotein A1 (APOA1)
Host
Mouse
Reactivity
Human
Recommended Dilution
Validated in IHC-F. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
Unconjugated
Isotype
IgG1
Purification
Purified
Size 1
500 µg
Form
Lyophilized
Tested Applications
ELISA, WB, IHC
Buffer
0.01 M Sodium Phosphate, 0.01 M Sodium Borate, 0.15M Sodium Chloride
Availability
Shipped within 3-7 working days.
Storage
Store lyophilized at 2°C to 8°C. After reconstitution, aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P02647
Gene ID
335
NCBI Accession
NP_000030.1
OMIM
105200
Alias
Apo A1,Apo-A1,apo(a), apolipoprotein A1, Apolipoprotein A-I,HPALP2,APOA1,Apolipoprotein AI
Background
Antibody anti-APOA1
Status
RUO

Descripción

APOA1 is the primary protein component of high-density lipoprotein (HDL), often referred to as "good cholesterol," where it plays a crucial role in reverse cholesterol transport. APOA1 facilitates the removal of cholesterol from peripheral tissues and delivers it to the liver for excretion via bile, thus protecting against atherosclerosis and cardiovascular disease. APOA1 is also an activator of lecithin-cholesterol acyltransferase (LCAT), an enzyme critical for HDL maturation and cholesterol esterification. Mutations in the APOA1 gene can result in familial HDL deficiency or amyloidosis, leading to cardiovascular dysfunction and systemic deposits of amyloid fibrils. As a key modulator of lipid metabolism, APOA1 is a major therapeutic target for managing dyslipidemia and reducing cardiovascular risk.

Related Products

EH0545

Human APOA1 (Apolipoprotein A-I) ELISA Kit

Ver Producto
FNab00488

APOA1 antibody

Participates in the reverse transport of cholesterol from tissues to the liver for excretion by promoting cholesterol efflux from tissues and by acting as a cofactor for the lecithin cholesterol acyltransferase(LCAT). As part of the SPAP complex, activates spermatozoa motility.

Ver Producto
FNab00508

APOA1 antibody

Ver Producto